|
Markt geschlossen -
NYSE
22:00:02 22.10.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 19.36 USD | +1.36% |
|
-15.16% | -18.76% |
| 10:17 | Arcus Biosciences platziert öffentliche Aktienemission im Volumen von 250 Mio. USD; Aktie vorbörslich im Minus | MT |
| 21.10. | Arcus Biosciences, Inc. : Bewertung von Wedbush zum Kaufen erhalten | ZM |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.36% | -14.77% | -27.61% | -35.10% | -18.38% | +15.77% | +20.21% | -44.95% | - | 2.43 Mrd. | |
| -4.10% | -8.35% | -15.87% | +11.75% | +55.90% | +38.48% | +66.99% | +0.08% | - | 66.22 Mrd. | |
| -0.41% | +3.27% | -8.42% | +3.30% | +9.29% | +10.46% | +73.74% | +213.86% | +5’405.27% | 55.2 Mrd. | |
| +0.74% | +4.04% | +11.62% | +17.11% | +16.81% | +12.18% | +91.76% | -16.79% | +247.65% | 52.79 Mrd. | |
| +0.62% | +2.10% | +2.46% | +39.40% | +22.77% | +27.02% | +50.63% | +7.72% | +271.25% | 45.53 Mrd. | |
| -1.05% | +2.20% | +3.86% | +19.49% | +25.84% | +21.93% | +126.58% | +0.90% | +1’053.59% | 43.94 Mrd. | |
| -3.37% | -0.76% | -2.61% | +2.62% | +135.82% | +254.53% | +923.32% | +588.02% | - | 41.64 Mrd. | |
| -1.67% | +8.06% | +7.11% | +13.23% | +12.72% | +14.17% | +56.67% | +8.66% | +160.85% | 34 Mrd. | |
| -8.38% | -9.01% | -14.60% | +16.59% | +43.96% | +25.65% | -1.82% | -59.98% | - | 25.84 Mrd. | |
| +1.30% | +4.94% | +16.45% | +38.88% | +30.93% | +38.23% | +28.03% | -11.27% | +131.99% | 23.51 Mrd. | |
| -1.75% | -0.75% | -11.25% | -2.52% | -5.97% | -15.73% | -3.24% | -67.84% | - | 22.93 Mrd. | |
| +1.05% | -4.46% | -21.55% | -11.12% | -45.54% | -40.91% | +280.66% | +245.30% | +573.67% | 20.54 Mrd. | |
| -1.55% | +3.71% | +3.45% | +23.45% | +16.08% | +19.24% | +186.54% | +248.56% | +1’996.94% | 18.49 Mrd. | |
| +1.10% | +3.81% | +12.17% | +18.63% | +48.81% | +80.78% | +238.83% | +204.79% | +477.72% | 16 Mrd. | |
| +2.92% | +5.18% | +5.45% | +17.97% | +33.43% | +31.99% | +76.59% | -19.09% | +94.46% | 15.76 Mrd. | |
| +1.63% | +6.72% | +1.80% | -4.00% | - | - | - | - | - | 15.69 Mrd. | |
| -1.39% | +10.43% | +18.62% | +54.64% | +69.54% | +80.85% | +86.59% | -19.60% | +308.34% | 16.46 Mrd. | |
| -1.28% | -2.52% | +0.87% | -1.28% | +173.78% | +148.41% | +360.63% | +1’423.97% | +739.98% | 15.01 Mrd. | |
| -5.37% | +2.42% | -9.64% | -12.45% | +14.18% | -4.93% | +517.23% | - | - | 14.41 Mrd. | |
| +0.18% | +4.83% | +9.86% | +9.75% | +0.75% | -4.68% | -17.61% | -33.85% | +115.88% | 14.29 Mrd. | |
| Durchschnitt | -1.09% | +2.69% | -0.89% | +11.02% | +33.72% | +39.66% | +166.44% | +148.25% | +890.58% | 28.03 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | -1.39% | +3.40% | -0.98% | +13.98% | +36.11% | +42.23% | +165.99% | +124.00% | +1’222.94% |
- Börse
- Aktien
- A2JGDZ Aktie
- Sektor Arcus Biosciences, Inc.
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
